Proqr Therapeutics Bv Stock Price Prediction
| PRQR Stock | USD 1.62 0.06 3.57% |
Momentum 30
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.16) | EPS Estimate Current Year (0.49) | EPS Estimate Next Year (0.62) | Wall Street Target Price 8.875 | EPS Estimate Current Quarter (0.18) |
Using ProQR Therapeutics hype-based prediction, you can estimate the value of ProQR Therapeutics BV from the perspective of ProQR Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ProQR Therapeutics using ProQR Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards ProQR using crowd psychology based on the activity and movement of ProQR Therapeutics' stock price.
ProQR Therapeutics Implied Volatility | 1.83 |
ProQR Therapeutics' implied volatility exposes the market's sentiment of ProQR Therapeutics BV stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ProQR Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ProQR Therapeutics stock will not fluctuate a lot when ProQR Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in ProQR Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying ProQR because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ProQR Therapeutics after-hype prediction price | USD 1.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out ProQR Therapeutics Basic Forecasting Models to cross-verify your projections. ProQR Therapeutics After-Hype Price Density Analysis
As far as predicting the price of ProQR Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ProQR Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ProQR Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ProQR Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting ProQR Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ProQR Therapeutics' historical news coverage. ProQR Therapeutics' after-hype downside and upside margins for the prediction period are 0.09 and 6.43, respectively. We have considered ProQR Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ProQR Therapeutics is risky at this time. Analysis and calculation of next after-hype price of ProQR Therapeutics is based on 3 months time horizon.
ProQR Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ProQR Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProQR Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ProQR Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.74 | 4.59 | 0.07 | 0.01 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.62 | 1.82 | 8.33 |
|
ProQR Therapeutics Hype Timeline
ProQR Therapeutics is at this time traded for 1.62. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.01. ProQR is projected to increase in value after the next headline, with the price projected to jump to 1.82 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 8.33%, whereas the daily expected return is at this time at -0.74%. The volatility of related hype on ProQR Therapeutics is about 30600.0%, with the expected price after the next announcement by competition of 1.61. The company has return on total asset (ROA) of (0.2402) % which means that it has lost $0.2402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0376) %, meaning that it created substantial loss on money invested by shareholders. ProQR Therapeutics' management efficiency ratios could be used to measure how well ProQR Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/28/2026, Return On Tangible Assets is likely to drop to -0.16. In addition to that, Return On Capital Employed is likely to drop to -0.22. At this time, ProQR Therapeutics' Other Current Assets are relatively stable compared to the past year. As of 01/28/2026, Net Tangible Assets is likely to grow to about 82.9 M, while Non Current Assets Total are likely to drop slightly above 8.9 M. Given the investment horizon of 90 days the next projected press release will be in about 4 days. Check out ProQR Therapeutics Basic Forecasting Models to cross-verify your projections.ProQR Therapeutics Related Hype Analysis
Having access to credible news sources related to ProQR Therapeutics' direct competition is more important than ever and may enhance your ability to predict ProQR Therapeutics' future price movements. Getting to know how ProQR Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ProQR Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IMMP | Immutep Ltd ADR | (0.10) | 5 per month | 2.87 | 0.14 | 7.41 | (5.41) | 31.54 | |
| EDIT | Editas Medicine | (0.13) | 8 per month | 0.00 | (0.17) | 6.56 | (9.13) | 21.57 | |
| CAPR | Capricor Therapeutics | (0.31) | 11 per month | 4.28 | 0.12 | 11.97 | (10.26) | 386.29 | |
| ACHV | Achieve Life Sciences | (0.18) | 9 per month | 0.00 | (0.03) | 5.86 | (6.40) | 24.72 | |
| ALLO | Allogene Therapeutics | (0.01) | 7 per month | 3.77 | 0.08 | 9.76 | (6.16) | 26.97 | |
| ARCT | Arcturus Therapeutics Holdings | 0.09 | 9 per month | 0.00 | (0.16) | 6.10 | (6.72) | 15.98 | |
| MREO | Mereo BioPharma Group | (0.07) | 8 per month | 0.00 | (0.01) | 16.33 | (9.52) | 101.95 | |
| VNDA | Vanda Pharmaceuticals | 0.20 | 10 per month | 4.87 | 0.12 | 11.39 | (6.34) | 39.51 | |
| TRDA | Entrada Therapeutics | 0.22 | 10 per month | 2.11 | 0.23 | 6.98 | (4.00) | 15.00 | |
| ZURA | Zura Bio Limited | 0.14 | 8 per month | 4.03 | 0.18 | 9.82 | (6.25) | 28.57 |
ProQR Therapeutics Additional Predictive Modules
Most predictive techniques to examine ProQR price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ProQR using various technical indicators. When you analyze ProQR charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ProQR Therapeutics Predictive Indicators
The successful prediction of ProQR Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ProQR Therapeutics BV, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ProQR Therapeutics based on analysis of ProQR Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ProQR Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ProQR Therapeutics's related companies. | 2018 | 2025 | 2026 (projected) | Payables Turnover | 7.29 | 210.49 | 221.01 | Days Of Inventory On Hand | 333.64 | 383.68 | 304.41 |
Pair Trading with ProQR Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProQR Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with ProQR Stock
| 0.75 | DRMA | Dermata Therapeutics | PairCorr |
| 0.67 | VINC | Vincerx Pharma Common | PairCorr |
| 0.83 | VYGR | Voyager Therapeutics | PairCorr |
| 0.82 | SLN | Silence Therapeutics PLC | PairCorr |
Moving against ProQR Stock
| 0.73 | MARUF | Marubeni Earnings Call This Week | PairCorr |
| 0.71 | HLN | Haleon plc | PairCorr |
| 0.68 | BFDE | Bedford Energy | PairCorr |
| 0.54 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.53 | CNOB | ConnectOne Bancorp Earnings Call Tomorrow | PairCorr |
| 0.48 | CAPR | Capricor Therapeutics | PairCorr |
The ability to find closely correlated positions to ProQR Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProQR Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProQR Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProQR Therapeutics BV to buy it.
The correlation of ProQR Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProQR Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProQR Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProQR Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ProQR Stock Analysis
When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.